Novartis has confirmed nine instances—seven of them newly disclosed—in which tumors have developed in children treated with ...

Researchers say to their knowledge the study represents the largest study to date of PFAS exposure and breast cancer ...

Not all DNA damage is equal. Every time a cell divides, it has to copy its DNA, and some stretches of the genome are harder to copy than others. Cancer cells depend on a protective response to get ...

Researchers at the University of Cambridge and Cambridge’s spin-out DIOSynVax, along with collaborators, reported on the development of a broad-spectrum bird flu vaccine that in animal trials provided ...

Its first program is an investigational therapy program for ornithine transcarbamylase deficiency, a rare, X-linked metabolic ...

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use.

Despite this advance, conventional CRISPR-Cas9 systems may introduce potentially harmful DNA breaks and cannot easily be ...

Principal Scientist, USP While payload design will remain a primary focus, the next era of innovation in CGT may ultimately ...

Lonza plans to more than double its U.S. footprint of CDMO sites by agreeing to acquire five such sites in the U.S. from ...

Study findings showed that the cancer cells organize themselves according to a consistent, predictable structural pattern ...

Researchers say findings establish HOX genes as potential therapeutic targets for enhancing bone regeneration.

A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause ...